Catherine A. High is the resident and chief scientific officer of Spark Therapeutics in Philadelphia, Pennsylvania.
Segment
Read More
12:06
Could Gene Therapy Be One Step Closer to the Clinic?
An experimental gene therapy for treating congenital blindness is reported to have positive outcomes in a Phase III clinical trial.